HC rejects petition by Novartis
HC dismisses a petition filed by Novartis, challenging the constitutional validity of the Sect 3 (d) of the patents (amendment) act 2005.
By PTI |
CHENNAI: The Madras High Court on Monday dismissed a petition filed by Swiss pharmaceutical major Novartis AG, challenging the constitutional validity of the Sect 3 (d) of the patents (amendment) act 2005, under which its patent application for beta crystalline form of imatinib mesylate, was rejected.
Dismissing it, a division bench comprising Justice R Balasubramanian and Justice Prabha Sridevan held that the Court cannot decide whether the Act was in accordance with trade related aspects of intellectual property rights (TRIPS) agreement or not.
Dismissing it, a division bench comprising Justice R Balasubramanian and Justice Prabha Sridevan held that the Court cannot decide whether the Act was in accordance with trade related aspects of intellectual property rights (TRIPS) agreement or not.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
